Square Step Exercises in Healthy Young Adults
NCT06331078, Not applicable, Not yet recruiting, Fenerbahce University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Square Step Exercises in Healthy Young Adults | ClinicalTrials.gov |
| NCT number | NCT06331078 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 50 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Fenerbahce University | ClinicalTrials.gov |
| Conditions | Exercise, Square Step Exercises, Aerobic Exercise, Cognitive Function, Physical Fitness | ClinicalTrials.gov |
| Interventions | Square Stepping Exercise training, Aerobic Exercise Training | ClinicalTrials.gov |
| First posted | 2024-03-26 | ClinicalTrials.gov |
| Last updated | 2025-08-19 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Schulte Grid Test | Baseline and after the interventions (4th week) | Schulte Grid Test will be used to evaluate the attention level of the participants. The task involves participants locating and selecting numbers in sequential order within a table filled with random numbers ranging from 1 to 64. Participants are required to find and click the correct numbers in ascending order, with completion time serving as the primary metric for assessment. Once a participant selects the correct number "1," the corresponding box will illuminate in green, prompting the participant to locate and select "2," and so forth until reaching "64." The test concludes upon successfully clicking the last number in the sequence. Schulte grid test will be conducted on a 15.6-inch laptop screen. A shorter reaction and completion time for the test will show good attention. | ClinicalTrials.gov |
| Primary | Stroop Test | Baseline and after the interventions (4th week) | This test will be used to evaluate executive functions, particularly selective attention and cognitive flexibility. In this assessment, participants are tasked with identifying the colors of rectangles, reading color names, and stating the color of color names printed in differing hues. Subsequently, error rates and spontaneous corrections are meticulously recorded and assessed. A shorter completion time and fewer number of errors for the test will show good executive functions. | ClinicalTrials.gov |
| Primary | Verbal Fluency Test | Baseline and after the interventions (4th week) | 1. Letter Fluency Test: Participants are instructed to count words beginning with the letters K, A, S, and non-numerical characters within one minute, while a voice recording is made. Words not starting with the specified letters and repeated words are tallied as errors/points. It is scored on the number of words derived. Repetition of the same word is considered as perseveration 2. Category Fluency Test: Participants are prompted to enumerate names of animals, fruits, and objects purchasable from the market within one minute, with a voice recording taken. Words falling outside the designated categories and repetitions are logged as error count/score. Total score based on the number of groups formed by the individual in one minute points are awarded. The more groups the individual has made, the more points individual gets. In this study, these tests will be utilized to assess information processing speed and attention as part of executive functions. | ClinicalTrials.gov |
| Primary | Digit Span Test | Baseline and after the interventions (4th week) | The test consists of two parts. Part One is Digits Forward and Part Two is Digits Backward. In both tests administered separately, random numbers are read to the participants at one-second intervals. The norm value of the Digits Forward is 7, while the norm value of the Digits Backward is 5; results below these values indicate impaired attention. | ClinicalTrials.gov |
| Primary | Vertical jump test | Baseline and after the interventions (4th week) | This test will be used for physical fitness assessment. During the assessment, the participant positions themselves adjacent to a wall. Using one arm, they extend upwards without bending, making contact with a wall marked in centimeters (cm). This measurement is then recorded. Following this, the participant is directed to perform a maximal force jump, aiming to touch the highest point achievable. This process is repeated thrice, with a 60-second rest interval between each jump. The highest value attained among the three jumps is documented in centimeters. | ClinicalTrials.gov |
| Primary | Horizontal jump test | Baseline and after the interventions (4th week) | In the assessment of horizontal jump, a key component of physical fitness, the standing long jump technique will be utilized. A designated starting line will be marked, with a ruler spanning 3 meters in length fixed at 1-centimeter intervals from the starting point. Participants will assume the starting position, ensuring their feet are not touching the line and are fully grounded, then execute a forward jump using both legs. The distance from the starting line to the point where the participant's feet last touch the ground will be measured. Each participant will perform three jumps, and the best distance achieved will be recorded as the final measurement. | ClinicalTrials.gov |
| Primary | Y Balance Test | Baseline and after the interventions (4th week) | Dynamic balance, an essential component of physical fitness crucial for executing functional tasks and occupational activities, will be evaluated using the Y balance test. This test involves reaching as far forward as possible along anterior, posterolateral, and posteromedial directional lines placed on the ground while maintaining balance on one foot. Participants will be instructed to reach as far as they can in each direction with their raised foot while keeping their hands on their hips. The maximum reach distances achieved in the anterior, posteromedial, and posterolateral directions will be marked and recorded as three valid measurements for each direction. The key outcome measures of interest will include the reach distances in the three directions as well as the composite score derived from the test. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Category Fluency | Primary outcome | ConductCognition |
| Digit Span Test | Primary outcome | ConductCognition |
| Ordered Number Search Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Verbal Fluency | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)